Trends in the prevalence of atrophic gastritis and Helicobacter pylori infection over a 10‑year period in Japan: The ROAD study 2005‑2015.

IF 1.4 Q4 ONCOLOGY Molecular and clinical oncology Pub Date : 2023-07-01 DOI:10.3892/mco.2023.2649
Izumi Inoue, Noriko Yoshimura, Toshiko Iidaka, Chiaki Horii, Shigeyuki Muraki, Hiroyuki Oka, Hiroshi Kawaguchi, Toru Akune, Takao Maekita, Kanae Mure, Kozo Nakamura, Sakae Tanaka, Masao Ichinose
{"title":"Trends in the prevalence of atrophic gastritis and Helicobacter pylori infection over a 10‑year period in Japan: The ROAD study 2005‑2015.","authors":"Izumi Inoue,&nbsp;Noriko Yoshimura,&nbsp;Toshiko Iidaka,&nbsp;Chiaki Horii,&nbsp;Shigeyuki Muraki,&nbsp;Hiroyuki Oka,&nbsp;Hiroshi Kawaguchi,&nbsp;Toru Akune,&nbsp;Takao Maekita,&nbsp;Kanae Mure,&nbsp;Kozo Nakamura,&nbsp;Sakae Tanaka,&nbsp;Masao Ichinose","doi":"10.3892/mco.2023.2649","DOIUrl":null,"url":null,"abstract":"<p><p>Few large population-based studies have examined the prevalence of atrophic gastritis (AG) and <i>Helicobacter pylori</i> infection in Japan. The purpose of the present study was to estimate the prevalence of AG and <i>H. pylori</i> infection by age, in addition to investigating their change rates from 2005 to 2016 in Japan using data from a large population-based cohort. A total of 3,596 participants [1,690 in the baseline survey (2005-2006) and 1,906 at the fourth survey (2015-2016)] aged 18 to 97 years were included in the cohort. The prevalence of AG and <i>H. pylori</i> infection were examined at baseline and in the fourth survey based on serological tests for the <i>H. pylori</i> antibody titer and pepsinogen levels. The prevalence of AG and <i>H. pylori</i> infection were 40.1% (men, 44.1%; women, 38.0%) and 52.2% (men, 54.8%; women, 50.8%), respectively, at baseline. AG seropositivity rates showed a significant decrease from 40.1 to 25.8% in 10 years. <i>H. pylori</i> seropositivity rates decreased significantly from 52.2 to 35.5% in 10 years. Stratified for age, the prevalence of AG showed an increasing trend with age, whereas the prevalence of <i>H. pylori</i> infection increased with aging, except for in the elderly group, showing an inverted U-shaped association. In this population-based, cross-sectional study with a 10-year interval survey, the prevalence of AG and <i>H. pylori</i> infection decreased significantly. This change may influence the prevalence of <i>H. pylori</i>-related diseases, including extra-gastric disorders associated with <i>H. pylori</i>-induced systemic subclinical inflammation and hypochlorhydria, such as colorectal neoplasia and arteriosclerosis.</p>","PeriodicalId":18737,"journal":{"name":"Molecular and clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/80/89/mco-19-01-02649.PMC10265571.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/mco.2023.2649","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Few large population-based studies have examined the prevalence of atrophic gastritis (AG) and Helicobacter pylori infection in Japan. The purpose of the present study was to estimate the prevalence of AG and H. pylori infection by age, in addition to investigating their change rates from 2005 to 2016 in Japan using data from a large population-based cohort. A total of 3,596 participants [1,690 in the baseline survey (2005-2006) and 1,906 at the fourth survey (2015-2016)] aged 18 to 97 years were included in the cohort. The prevalence of AG and H. pylori infection were examined at baseline and in the fourth survey based on serological tests for the H. pylori antibody titer and pepsinogen levels. The prevalence of AG and H. pylori infection were 40.1% (men, 44.1%; women, 38.0%) and 52.2% (men, 54.8%; women, 50.8%), respectively, at baseline. AG seropositivity rates showed a significant decrease from 40.1 to 25.8% in 10 years. H. pylori seropositivity rates decreased significantly from 52.2 to 35.5% in 10 years. Stratified for age, the prevalence of AG showed an increasing trend with age, whereas the prevalence of H. pylori infection increased with aging, except for in the elderly group, showing an inverted U-shaped association. In this population-based, cross-sectional study with a 10-year interval survey, the prevalence of AG and H. pylori infection decreased significantly. This change may influence the prevalence of H. pylori-related diseases, including extra-gastric disorders associated with H. pylori-induced systemic subclinical inflammation and hypochlorhydria, such as colorectal neoplasia and arteriosclerosis.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
日本萎缩性胃炎和幽门螺杆菌感染流行趋势10年:2005 - 2015年ROAD研究
在日本,很少有大型基于人群的研究调查了萎缩性胃炎(AG)和幽门螺杆菌感染的患病率。本研究的目的是根据年龄估计AG和幽门螺杆菌感染的患病率,并使用基于大型人群队列的数据调查2005年至2016年日本AG和幽门螺杆菌感染的变化率。共有3596名参与者(基线调查(2005-2006)为1690名,第四次调查(2015-2016)为1906名),年龄在18至97岁之间。在基线和基于幽门螺杆菌抗体滴度和胃蛋白酶原水平的血清学测试的第四次调查中,检查了AG和幽门螺杆菌感染的患病率。AG和幽门螺杆菌感染率分别为40.1%(男性44.1%;女性,38.0%)和52.2%(男性,54.8%;女性,50.8%)。血清抗原阳性率在10年间从40.1下降到25.8%。10年间幽门螺杆菌血清阳性率由52.2%显著下降至35.5%。按年龄分层,AG患病率随年龄增长呈上升趋势,而幽门螺杆菌感染率随年龄增长呈上升趋势,除老年组外,呈倒u型关系。在这项以人群为基础、间隔10年的横断面研究中,AG和幽门螺杆菌感染的患病率显著下降。这种变化可能影响幽门螺杆菌相关疾病的患病率,包括与幽门螺杆菌引起的全身亚临床炎症和低氯酸血症相关的胃外疾病,如结肠直肠癌和动脉硬化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
108
期刊最新文献
Breast cancer radiobiology: The renaissance of whole breast radiation fractionation (Review). A computed tomography‑based radio‑clinical model for the prediction of microvascular invasion in gastric cancer. Clinical parameters and postoperative outcomes of pituitary adenomas in children: Analysis according to size of adenomas and adopted surgical procedures. Incidence of myelosuppression in AML is higher compared with that in ALL. Efficacy and safety of second‑generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta‑analysis of randomized controlled trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1